What happens when I stop taking GLP-1s? Will I regain the weight?

Short answer: yes — many people regain at least some (often most) of the weight they lost after stopping GLP‑1 drugs unless they keep strong lifestyle/behavior changes or switch to another maintenance strategy. How much and how fast varies, but appetite and physiology that the drug was suppressing typically return.

Why that happens

• GLP‑1 receptor agonists (eg, semaglutide — Wegovy/Ozempic/Rybelsus, tirzepatide — Zepbound/Mounjaro) reduce appetite and calories and change metabolism. When the drug is stopped those effects reverse: hunger increases, satiety falls, and the body defends a higher weight (metabolic “set point” and lower resting energy expenditure).
• Clinical trials consistently show weight regain after stopping these drugs unless other measures are firmly in place.

What you may notice after stopping

• Increased appetite/cravings and weight gain over weeks–months (degree varies).
• If you have diabetes, blood glucose and A1c may rise and need monitoring/adjustment.
• GI side effects from the drug resolve; no severe physical “withdrawal,” but the return of hunger can feel like one.

Evidence summary (high level)

• Long-term trial extensions and discontinuation analyses for semaglutide and tirzepatide report substantial weight regain once the drug is stopped. Some people keep a portion of the loss, but most regain a meaningful amount within months to a year.

How to reduce the chance of regaining weight

• Plan ahead with your clinician before stopping. A taper or stop should be part of a strategy (though tapering hasn’t been proven to prevent regain).
• Intensify lifestyle and behavioral supports before and after stopping: structured meal plan, higher protein intake, regular resistance and aerobic exercise, sleep, stress management, and possibly formal programs (dietitian, weight‑management clinic, behavioral therapy).
• Consider transition/maintenance medications if appropriate: other anti‑obesity drugs (phentermine‑topiramate/Qsymia, bupropion/naltrexone/Contrave, liraglutide/Saxenda) or continuing a GLP‑1 at a lower dose may be options to discuss with your prescriber. For people with diabetes, alternative glucose‑lowering meds may be needed.
• Monitor weight and metabolic labs regularly so you can act early if weight begins to return.
• For some people with severe obesity, bariatric surgery is an effective long‑term option.

Practical next steps

1. Talk with your prescriber before stopping. Discuss reasons to stop, risks, and a tailored plan (diet, exercise, monitoring, med alternatives).
2. If you have diabetes, arrange closer glucose/A1c monitoring and medication adjustments.
3. Start or intensify structured lifestyle supports now (dietitian, exercise plan, behavioral counseling).
4. Consider a weight‑management specialist if you’ve lost a lot of weight or have trouble keeping it off.

If you tell me why you’re stopping (side effects, cost, pregnancy, finished course), your medical history (diabetes?), and which GLP‑1 you’re on, I can give more specific, personalized steps and alternative treatment options.